report-pricing-dollar

Maternal Mental Health Market

Pages:
199
View Count:
9336
Delivery Formats:
PDF PPT Excel
Maternal Mental Health Market

Lowest Price Guaranteed

download button Download Free Sample

sales@rootsanalysis.com

buynow button Buy Now

+44 (748) 188 1310

Maternal Mental Health Market by Type of Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, and Other Disease Indications), Type of Therapy, Geographical Regions, and Leading Players – Trends and Forecast, 2026-2035

Maternal Mental Health Market Overview

The global maternal mental health market, valued at USD 13 billion in 2025, is projected to reach USD 17 billion in 2026 and USD 123 billion by 2035, representing a CAGR of 24.6% during the forecast period 2026 to 2035.

Global Maternal Mental Health Market Growth 2020 to 2035

See What’s in the Full Report - Request Your Complimentary Insights!

Market Report: Key Takeaways

Market Size and Trends

  • In terms of therapy, the interpersonal psychotherapy (IPT) is dominating by securing 40% of the overall revenue share due to the growing usage, especially for postpartum depression.
  • With respect to geographical regions, North America dominates the market with a 42% share, driven by high demand for perinatal depression screening, rising mental health issues, and government-backed mental health programs.
  • Based on disease indication, the pregnancy and postpartum general anxiety segment dominates the market by securing 35% of the overall revenue share.
  • The market is expected to remain progressive, with telehealth services, wearable monitoring, and AI-driven personalized interventions playing crucial roles in delivering therapies globally.

Key Market Statistics

  • Market Size in 2026: $17 Billion
  • Estimated Market Size in 2035: $123 Billion
  • CAGR (2025-2035): 24.6%
  • North America: Largest market in 2026
  • Asia Pacific: Fastest growing region

Market Introduction

The market for maternal mental health is rapidly growing driven by the growing emphasis on post-pregnancy women health. It is important to highlight here that women several physical and physiological changes, which result into anxiety, and postpartum depression. The untreated condition not only impacts mother's health but overall affect newborn's well-being. Moreover, the postpartum depression can also increase the risk of chronic health conditions in women.

Owing to the ongoing concerns, the healthcare industry and World Health Organizations are focusing on early detection, maternal health supportive programs and treatments to promote maternal mental health. Interestingly, the market players have undertaken several initiatives to develop therapeutic drugs, women health app, mobile applications, digital health solutions for close monitoring and offering real-time support.

For instance, in January 2025, Johnson & Johnson (US) announced the approval of supplemental new drug application for SPRAVATO® (esketamine) CIII nasal spray. It is first-of-its-kind monotherapy for adults with depressive disorder. Moreover, several industrial players are encouraging the development of advanced women's digital health solutions and antidepressant drugs to manage maternal mental health and improve overall well-being. The consistent focus on women health is likely to fuel the maternal mental health market in the future.

Have Questions? Let’s Get Them Answered

Market Segmentation

Based on the research, we have segmented the maternal mental health market into type of disease indication, type of therapy, geographical regions, and leading players.

Maternal Mental Health Market, by Type of Disease Indication

  • Postpartum Depression
  • Dysthymia
  • Pregnancy and Postpartum General Anxiety
  • Pregnancy and Postpartum OCD
  • Birth-Related PTSD
  • Other Disease Indications

Maternal Mental Health Market, by Type of Therapy

  • Antidepressants
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Tricyclic Antidepressants (TCAs)
    • Others
  • Interpersonal Psychotherapy (IPT)
  • Cognitive Behavioral Therapy (CBT)
  • Other Therapies

Maternal Mental Health Market, by Geographical Regions

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • New Zealand
    • Rest of the Asia-Pacific
  • Middle East & Africa
    • Egypt
    • Iran
    • Iraq
    • Israel
    • Saudi Arabia
    • South Africa
    • United Arab Emirates
  • Latin America
    • Argentina
    • Brazil

Pay Only for What You Need – The Best Way to Optimize

Maternal Mental Health Market Key Insights

Maternal Mental Health Market Drivers: What are the Key Factors for Market Growth?

Several factors that are propelling maternal mental health market growth include rising prevalence of postpartum depression and rising awareness about mental health. It is important to highlight that the growing incidence of postpartum depression has also necessitated the demand for maternal mental health screening in prenatal care solutions for optimal care of women and newborn babies. Moreover, considering the ongoing demand, the market players are also emphasizing on the group therapy programs for pregnant and new mothers, which further likely to fuel the market growth.

Maternal Mental Health Market Challenges: What Factors are Limiting Market Growth?

Despite of immense growth potential, the maternal mental health solutions market is witnessing several challenges. Some of the notable challenges are lack of mental health professionals and socioeconomic factors. It is important to highlight here that the healthcare industry is currently witnessing scarcity of professional mental healthcare experts for maternal health. Due to the shortage of skilled personnel, postpartum women may not receive optimal care from the healthcare professionals. Additionally, the high treatment cost may seem like a barrier for women specifically in rural areas.

What are the Current Trends in Screening, Prevention, and Reimbursement for Maternal Mental Health Care?

Some of the notable trends that are shaping market growth includes rising technological advancements and availability of insurance coverage for maternal mental health services. It is worth noting that the market players are greatly emphasizing the development of AI-powered early detection of maternal mental health risks so women can receive early treatment. In addition, the industrial players are developing women health apps for real-time monitoring of sleep pattern, cognitive behavior and other vital health signs. Moreover, the growing focus on research and development activities to develop antidepressant drugs is likely to fuel the maternal mental health market growth in the future.

Recent Developments in Maternal Mental Health Market

Several recent developments in the field of maternal mental health have occurred and we have outlined some of these below:

  • In August 2025, Tia (US) entered into a partnership with Talkspace (US) to enhance the mental health services by integrating its primary women care.
  • In February 2025, Apple (US) has launched Apple Health Study in collaboration with Harvard Medical School, Brigham and Women's Hospital to understand how technology, including Apple Watch, iPHone and AirPods can help in improving mental health and overall wellbeing.
  • In February 2025, Ovum (US) raised USD 1.7 million to launch artificial intelligence health assistance for women. This AI based health assistance, Ovum will create women-specific AI platform and datasets that can store blood tests data and other vital information to share on women health app.
  • In February 2025, Ijeoma Uche (a medical student at UC Davis School of Medicine) has created an AI powered app "Birth By Us". This is a pregnancy, childbirth and postpartum platform that utilize AI-algorithm and data analytics to empower families for healthy perinatal experience.

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

Industry Experts on Maternal Mental Health Market

Maternal mental health industry is gaining recognition driven by the rising awareness about consequences associated with postpartum depression.

Raysa Bousleiman (the co-author of the report and senior vice president for Investor Coverage in Life Science and Healthcare at SVB), stated that, "Investment in women's health continues to reach new milestones, driven by a growing recognition of the ways in which health conditions impact women differently. While 2025 may present challenges, the long-term potential of the sector is clear, and we expect continued investment focused on addressing the unmet healthcare needs for women."

Market Share Insights

Which Disease Indication Segment will Propel in the Future?

  • This segment reflects the distribution of global market across different type of disease indication, such as postpartum depression, dysthymia, pregnancy and postpartum general anxiety, pregnancy and postpartum OCD, birth-related PTSD, and other disease indications. According to the maternal mental health market report, the pregnancy and postpartum general anxiety segment holds the highest share (35%) of the market. This growth stems from the increasing awareness about generalized anxiety disorder, and depression during pregnancy and postpartum. Several efforts have been taken by the government organizations and healthcare industry to mitigate the concern of postpartum depression.
  • It is important to highlight here that the postpartum depression segment is likely to grow at a higher CAGR in the future due to the rising prevalence of postpartum depression. According to the National Institute of Health, around 1 in 7 women during pregnancy suffer from severe mood disorder within the first year after childbirth. The rising prevalence has necessitated the demand for digital maternal mental health tools for early detection and treatment of depression.
Maternal Mental Health Market Size by Type of Disease Indication 2026

Will Interpersonal Psychotherapy Segment Dominate in the Upcoming Years?

  • The global market is categorized across different types of therapy, such as antidepressants (selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and other therapies), interpersonal psychotherapy (IPT), cognitive behavioral therapy (CBT), and others. According to the maternal mental health market forecast, interpersonal psychotherapy is dominating the market by 40% of the overall revenue share. This is due to the fact that interpersonal psychotherapy is widely used as transdiagnostic treatment to treat postpartum depression.
  • The antidepressants segment is likely to grow at a higher CAGR during the forecast period. This can be attributed to the rising usage of antidepressant medications in conjunction with other treatment to treat depression in women. Antidepressants alter the synthetic of certain molecules associated with mood and stress.

Regional Analysis: Which Region is Dominating the Market?

North America: Leading with 42% of the Market Share

According to the maternal mental health industry analysis, North America is dominating the market due to the growing demand for perinatal depression screening solutions. This can be ascribed to the rising incidence of mental health issues, such as pregnancy depression, anxiety, stress and postpartum depression. Moreover, the government organizations in this region are expanding mental health programs to help women aware about health issues, latest technological innovations and apps available to treat mental issues.

Europe: Secured Second Largest Share of the Market

Europe region holds the substantial maternal mental health market share. This significant share is due to the advanced healthcare infrastructure and increase public and private healthcare programs to support maternal health. Moreover, Europe has a highly established maternal health sector to support mother health during pregnancy, childbirth and post-pregnancy. The highly established healthcare infrastructure will continue to surge the demand for advanced therapies and digital maternal mental health tools to support maternal health.

Maternal Mental Health Market Outlook by Geographical Regions 2026

Want Information on Specific Region / Segment?

Asia-Pacific: Emerging as a Hotspot

Asia-Pacific region is likely to witness higher CAGR and secure a significant share of the maternal mental health market size in the future. This growth stems from the rising prevalence of postpartum depression and growing focus on community-based maternal mental health programs to enhance the overall wellbeing of women. It is important to highlight here that in March 2025, a multiuser interactive health response application (MITHRA) for depression in women has been developed by a community-based organization in India. This program aims to support women maternal mental health and offer brief behavioral intervention for mild to moderate depression among rural women attending self-help groups in India.

How are Digital Tools Shaping Maternal Mental Health Services?

Digital healthcare tools are the future of maternal mental health market. Technologies, such as maternal mental health telehealth platforms and mobile applications are widely adopted by healthcare practitioners to enhance accessibility of medical services to manage depression in women. Moreover, mobile mental health apps for expecting mothers provide a secure and safe environment for remote mental health consultation. Notably, personalized and interactive support will be the key trend of the market, which is likely to shape market growth in the future.

Maternal Mental Health Market: Scope of the Report

Key Report Attributes Details
Historical Trend Since 2020
Forecast Period Till 2035
Market Size 2026 USD 17 Billion
Market Size 2035 USD 123 Billion
CAGR (Till 2035) 24.6%
Key Players Profiled
  • AstraZeneca (UK)
  • Alembic Pharmaceuticals (India)
  • Bausch Health (US)
  • Brightside Health (US)
  • Canopie (US)
  • Eli Lilly (US)
  • GSK (UK)
  • March of Dimes (US)
  • Mammha (US)
  • Mallinckrodt (Ireland)
  • Magellan Health (US)
  • Sage Therapeutics (US)
  • Pfizer (US)
  • Viatris (US)
(A complete list of companies captured is available in the report)
Segments Covered
  • Type of Disease Indication
  • Type of Therapy
  • Geographical Regions
Excel Data Packs
(Complimentary)
  • Market Landscape
  • Company Competitiveness Analysis
  • Startup Ecosystem Analysis
  • Partnership & Collaboration Analysis
  • Funding & Investment Analysis
  • Market Forecast and Opportunity Analysis
PowerPoint Presentation
(Complimentary)
Available
Customization Scope 15% Free Customization

Frequently Asked Questions